Roger M. Perlmutter

Exe VP, Research & Development, Amgen.

Companies

Eikon Therapeutics, Inc.Board member Feb 4, 2026 to now¹
Eikon Therapeutics, Inc.Officer Feb 4, 2026 to now¹
NGM Biopharmaceuticals (United States)Board member Jun 10, 2021 to Apr 8, 2024²
Merck & Co.Exe V-P & Pres, MRL Apr 23, 2013 to May 5, 2020³
Microbot Medical Inc.Board member Dec 14, 2006 to Dec 14, 2012⁴
AmgenExe VP, Research & Development Apr 4, 2006 to Feb 6, 2012⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Eikon Therapeutics, Inc. EIKN1,475,856 shares⁶$11.8M at $8.02Feb 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Feb 6, 2026Converted 284,857 shares of Eikon Therapeutics, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAREikon Therapeutics, Inc., Board member
2
SEC EDGARNGM Biopharmaceuticals (United States), Board member
3
SEC EDGARMerck & Co., Exe V-P & Pres, MRL
4
SEC EDGARMicrobot Medical Inc., Board member
5
SEC EDGARAmgen, Exe VP, Research & Development
6
SEC EDGAREikon Therapeutics, Inc. shares after the filing of Feb 6, 2026